Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Review ArticleClinical Review

Improvement in Lung Cancer Outcomes With Targeted Therapies: An Update for Family Physicians

Christian Rolfo, Francesco Passiglia, Marcin Ostrowski, Lúcia Farracho, Tereza Ondøichová, Ana Dolcan, Marta Castiglia, Roy Remmen, Konstantinos Papadimitriou and Patrick Pauwels
The Journal of the American Board of Family Medicine January 2015, 28 (1) 124-133; DOI: https://doi.org/10.3122/jabfm.2015.01.140072
Christian Rolfo
From the Phase I Early Clinical Trials Unit, Department of Oncology, Antwerp University Hospital, Edegem, Belgium (CR, FP, KP); European Cancer Organisation, Antwerp University Hospital, Edegem, Belgium (MO, LF, TO, AD); Molecular Pathology Unit, Department of Pathology, Antwerp University Hospital, Edegem, Belgium (MC, PP); and the Faculty of Medicine and Health Sciences, Antwerp University Hospital, Edegem, Belgium (RR).
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesco Passiglia
From the Phase I Early Clinical Trials Unit, Department of Oncology, Antwerp University Hospital, Edegem, Belgium (CR, FP, KP); European Cancer Organisation, Antwerp University Hospital, Edegem, Belgium (MO, LF, TO, AD); Molecular Pathology Unit, Department of Pathology, Antwerp University Hospital, Edegem, Belgium (MC, PP); and the Faculty of Medicine and Health Sciences, Antwerp University Hospital, Edegem, Belgium (RR).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcin Ostrowski
From the Phase I Early Clinical Trials Unit, Department of Oncology, Antwerp University Hospital, Edegem, Belgium (CR, FP, KP); European Cancer Organisation, Antwerp University Hospital, Edegem, Belgium (MO, LF, TO, AD); Molecular Pathology Unit, Department of Pathology, Antwerp University Hospital, Edegem, Belgium (MC, PP); and the Faculty of Medicine and Health Sciences, Antwerp University Hospital, Edegem, Belgium (RR).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lúcia Farracho
From the Phase I Early Clinical Trials Unit, Department of Oncology, Antwerp University Hospital, Edegem, Belgium (CR, FP, KP); European Cancer Organisation, Antwerp University Hospital, Edegem, Belgium (MO, LF, TO, AD); Molecular Pathology Unit, Department of Pathology, Antwerp University Hospital, Edegem, Belgium (MC, PP); and the Faculty of Medicine and Health Sciences, Antwerp University Hospital, Edegem, Belgium (RR).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tereza Ondøichová
From the Phase I Early Clinical Trials Unit, Department of Oncology, Antwerp University Hospital, Edegem, Belgium (CR, FP, KP); European Cancer Organisation, Antwerp University Hospital, Edegem, Belgium (MO, LF, TO, AD); Molecular Pathology Unit, Department of Pathology, Antwerp University Hospital, Edegem, Belgium (MC, PP); and the Faculty of Medicine and Health Sciences, Antwerp University Hospital, Edegem, Belgium (RR).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Dolcan
From the Phase I Early Clinical Trials Unit, Department of Oncology, Antwerp University Hospital, Edegem, Belgium (CR, FP, KP); European Cancer Organisation, Antwerp University Hospital, Edegem, Belgium (MO, LF, TO, AD); Molecular Pathology Unit, Department of Pathology, Antwerp University Hospital, Edegem, Belgium (MC, PP); and the Faculty of Medicine and Health Sciences, Antwerp University Hospital, Edegem, Belgium (RR).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marta Castiglia
From the Phase I Early Clinical Trials Unit, Department of Oncology, Antwerp University Hospital, Edegem, Belgium (CR, FP, KP); European Cancer Organisation, Antwerp University Hospital, Edegem, Belgium (MO, LF, TO, AD); Molecular Pathology Unit, Department of Pathology, Antwerp University Hospital, Edegem, Belgium (MC, PP); and the Faculty of Medicine and Health Sciences, Antwerp University Hospital, Edegem, Belgium (RR).
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roy Remmen
From the Phase I Early Clinical Trials Unit, Department of Oncology, Antwerp University Hospital, Edegem, Belgium (CR, FP, KP); European Cancer Organisation, Antwerp University Hospital, Edegem, Belgium (MO, LF, TO, AD); Molecular Pathology Unit, Department of Pathology, Antwerp University Hospital, Edegem, Belgium (MC, PP); and the Faculty of Medicine and Health Sciences, Antwerp University Hospital, Edegem, Belgium (RR).
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Konstantinos Papadimitriou
From the Phase I Early Clinical Trials Unit, Department of Oncology, Antwerp University Hospital, Edegem, Belgium (CR, FP, KP); European Cancer Organisation, Antwerp University Hospital, Edegem, Belgium (MO, LF, TO, AD); Molecular Pathology Unit, Department of Pathology, Antwerp University Hospital, Edegem, Belgium (MC, PP); and the Faculty of Medicine and Health Sciences, Antwerp University Hospital, Edegem, Belgium (RR).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Pauwels
From the Phase I Early Clinical Trials Unit, Department of Oncology, Antwerp University Hospital, Edegem, Belgium (CR, FP, KP); European Cancer Organisation, Antwerp University Hospital, Edegem, Belgium (MO, LF, TO, AD); Molecular Pathology Unit, Department of Pathology, Antwerp University Hospital, Edegem, Belgium (MC, PP); and the Faculty of Medicine and Health Sciences, Antwerp University Hospital, Edegem, Belgium (RR).
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 28 no. 1 124-133
DOI 
https://doi.org/10.3122/jabfm.2015.01.140072
PubMed 
25567833

Published By 
The Journal of the American Board of Family Medicine
Print ISSN 
1557-2625
Online ISSN 
1558-7118
History 
  • Received for publication February 26, 2014
  • Revision received September 7, 2014
  • Accepted for publication September 25, 2014
  • Published online January 7, 2015.

Copyright & Usage 
© Copyright 2015 by the American Board of Family Medicine.

Author Information

  1. Christian Rolfo, MD, PhD,
  2. Francesco Passiglia, MD,
  3. Marcin Ostrowski, MD,
  4. Lúcia Farracho,
  5. Tereza Ondøichová,
  6. Ana Dolcan,
  7. Marta Castiglia, BSc,
  8. Roy Remmen, MD, PhD,
  9. Konstantinos Papadimitriou, MD and
  10. Patrick Pauwels, MD, PhD
  1. From the Phase I Early Clinical Trials Unit, Department of Oncology, Antwerp University Hospital, Edegem, Belgium (CR, FP, KP); European Cancer Organisation, Antwerp University Hospital, Edegem, Belgium (MO, LF, TO, AD); Molecular Pathology Unit, Department of Pathology, Antwerp University Hospital, Edegem, Belgium (MC, PP); and the Faculty of Medicine and Health Sciences, Antwerp University Hospital, Edegem, Belgium (RR).
  1. Corresponding author: Christian Rolfo, MD, PhD, Phase I Early Clinical Trials Unit, Department of Oncology, Antwerp University Hospital, Edegem, Belgium, UZA, Wilrijkstraat 10, 2650 Edegem, Belgium (E-mail: christian.rolfo{at}uza.be).
View Full Text
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 28 (1)
The Journal of the American Board of Family Medicine
Vol. 28, Issue 1
January-February 2015
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Improvement in Lung Cancer Outcomes With Targeted Therapies: An Update for Family Physicians
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
11 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Improvement in Lung Cancer Outcomes With Targeted Therapies: An Update for Family Physicians
Christian Rolfo, Francesco Passiglia, Marcin Ostrowski, Lúcia Farracho, Tereza Ondøichová, Ana Dolcan, Marta Castiglia, Roy Remmen, Konstantinos Papadimitriou, Patrick Pauwels
The Journal of the American Board of Family Medicine Jan 2015, 28 (1) 124-133; DOI: 10.3122/jabfm.2015.01.140072

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Improvement in Lung Cancer Outcomes With Targeted Therapies: An Update for Family Physicians
Christian Rolfo, Francesco Passiglia, Marcin Ostrowski, Lúcia Farracho, Tereza Ondøichová, Ana Dolcan, Marta Castiglia, Roy Remmen, Konstantinos Papadimitriou, Patrick Pauwels
The Journal of the American Board of Family Medicine Jan 2015, 28 (1) 124-133; DOI: 10.3122/jabfm.2015.01.140072
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • EGFR Pathway and EGFR Inhibitors
    • ALK Translocation and ALK Inhibitors
    • Emerging Toxicities and Management
    • Future Perspectives and Conclusions
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer: Results From PROFILE 1014
  • Practical, Office-based Interventions That Improve Care Today
  • Google Scholar

More in this TOC Section

  • Interpretating Normal Values and Reference Ranges for Laboratory Tests
  • Non-Surgical Management of Urinary Incontinence
  • Screening and Diagnosis of Type 2 Diabetes in Sickle Cell Disease
Show more Clinical Reviews

Similar Articles

Keywords

  • Cancer
  • Drug Therapy
  • Lung Cancer
  • Medical Oncology
  • Non-Small-Cell Lung Cancer
  • Tyrosine Kinase

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire